Literature DB >> 12611395

5-HT1A receptor agonist 8-OH-DPAT acts in the hindbrain to reverse the sympatholytic response to severe hemorrhage.

Karie E Scrogin1.   

Abstract

Central administration of serotonergic 5-HT1A receptor agonists delays the reflex sympatholytic response to severe hemorrhage in conscious rats. To determine the region where 5-HT1A receptor agonists act to mediate this response, recovery of mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) was compared in hemorrhaged rats after injection of the selective 5-HT1A agonist, (+)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), in various regions of the cerebroventricular system or the systemic circulation. Three minutes after injection of 8-OH-DPAT (48 nmol/kg), MAP and RSNA were higher in hemorrhaged rats given drug in the fourth ventricle (94 +/- 5 mmHg, 82 +/- 18% of baseline) or the systemic circulation (90 +/- 4 mmHg, 113 +/- 15% of baseline) than in rats given drug in the Aqueduct of Sylvius (63 +/- 4 mmHg, 27 +/- 11% of baseline), the lateral ventricle (42 +/- 3 mmHg, -8 +/- 18% of baseline), or in rats given saline in various brain regions (47 +/- 5 mmHg, -42 +/- 10% of baseline). A lower-dose injection of 8-OH-DPAT (10 nmol/kg) also accelerated the recovery of MAP and RSNA in hemorrhaged rats when given in the fourth ventricle (94 +/- 26 mmHg, 72 +/- 33% of baseline 3 min after injection) but not the systemic circulation (46 +/- 4 mmHg, -25 +/- 30% of baseline). These data indicate that 8-OH-DPAT acts on receptors in the hindbrain to reverse the sympatholytic response to hemorrhage in conscious rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611395     DOI: 10.1152/ajpregu.00478.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Serotonin nerve terminals in the dorsomedial medulla facilitate sympathetic and ventilatory responses to hemorrhage and peripheral chemoreflex activation.

Authors:  Ling-Hsuan Kung; Karie E Scrogin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

3.  Daily voluntary exercise alters the cardiovascular response to hemorrhage in conscious male rats.

Authors:  Joslyn K Ahlgren; Linda F Hayward
Journal:  Auton Neurosci       Date:  2011-01-06       Impact factor: 3.145

4.  5-HT1A receptors of the nucleus tractus solitarii facilitate sympathetic recovery following hypotensive hemorrhage in rats.

Authors:  Jaime E Vantrease; Nichole Dudek; Lydia L DonCarlos; Karie E Scrogin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-15       Impact factor: 4.733

5.  Serotonin neurons of the caudal raphe nuclei contribute to sympathetic recovery following hypotensive hemorrhage.

Authors:  Ling-Hsuan Kung; Jaimee Glasgow; Anna Ruszaj; Thackery Gray; Karie E Scrogin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-03       Impact factor: 3.619

Review 6.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

7.  The spleen is required for 5-HT1A receptor agonist-mediated increases in mean circulatory filling pressure during hemorrhagic shock in the rat.

Authors:  Ruslan Tiniakov; Karie E Scrogin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-25       Impact factor: 3.619

8.  Regional differences in serotonin content in the nucleus of the solitary tract of male rats after hypovolemia produced by polyethylene glycol.

Authors:  J Thomas Curtis; Michael B Anderson; Kathleen S Curtis
Journal:  J Physiol Sci       Date:  2012-09-04       Impact factor: 2.781

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.